ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to CLL
Related studies linked through entity extraction aliases.
A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients
- Status
- UNKNOWN
- Phase
- N/A
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- N/A
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
- Status
- TERMINATED
- Phase
- PHASE2
Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
- Status
- TERMINATED
- Phase
- PHASE2
Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- N/A
Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
- Status
- UNKNOWN
- Phase
- PHASE2
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Transplantation From Related Haploidentical Donors
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2